IMAJ | volume 26
Journal 7, July - August 2024
pages: 405-409
1 Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
2 Department of Obstetrics and Gynecology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
3 Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
4 Bornstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel
5 Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Summary
Background:
Data regarding the management of adnexal torsion (AT) during the coronavirus disease 2019 (COVID-19) pandemic are scarce.
Objectives:
To study the effects of actions to limit the spread of COVID-19 on AT management.
Methods:
We conducted a retrospective cohort study of all women who underwent laparoscopy for suspected AT between March 2011 and February 2021. We compared the COVID-19 pandemic period, (15 March 2020–2 August 2021, group A) to a parallel period (2019–2020, group B), and a 9-year period preceding the pandemic (March 2011–February 2020, group C).
Results:
We performed 97 laparoscopies in group A, 82 in group B, and 635 in group C. The proportion of women presenting following in vitro fertilization treatment was lower (odds ratio [OR]
0.22, 95% confidence interval
]95%CI] (0.06–0.86),
P < 0.023). Time from admission to decision to operate was shorter (2.7 vs. 3.9 hours,
P = 0.028) in group A than group B. Time from admission to surgery was shorter (9.1 vs. 12.5 hours,
P = 0.005) and the rate of surgically confirmed AT was lower (59 [60.8%] vs. 455 [71.7%],
P = 0.030, OR 0.61, 95%CI 0.39–0.95) in group A than group C. Among surgically confirmed AT cases only, mean time from admission to decision was shorter in group A than group B (2.6 vs. 4.6 hours,
P = 0.014).
Conclusions:
We identified differences in time from admission to clinical decision and from admission to surgery among women with suspected AT during the COVID-19 pandemic.